Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients With Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations
(2022)
Journal Article
R. Jadon, D., Corp, N., Van Der Windt, D., C. Coates, L., R. Soriano, E., Kavanaugh, A., Raine, T., Rieder, F., Siebert, S., Zummer, M., Schwartzman, S., T. Rosenbaum, J., Michelsen, B., Laxminarayan, R., Wu, D., Gupta, L., Ng, B., Jethwa, H., De Windt, N., Gudu, T., …Elaine Husni, M. (2023). Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients With Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology, 50(3), 438-450. https://doi.org/10.3899/jrheum.220317
Objective: Several advanced therapies have been licensed across the related conditions of psoriatic arthritis (PsA), Crohn disease (CD), ulcerative colitis (UC), and noninfectious uveitis. We sought to summarize results from randomized controlled tri... Read More about Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients With Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.